Literature DB >> 26142241

Insomnia in women approaching menopause: Beyond perception.

Fiona C Baker1, Adrian R Willoughby2, Stephanie A Sassoon2, Ian M Colrain3, Massimiliano de Zambotti2.   

Abstract

The menopausal transition is marked by increased prevalence in disturbed sleep and insomnia, present in 40-60% of women, but evidence for a physiological basis for their sleep complaints is lacking. We aimed to quantify sleep disturbance and the underlying contribution of objective hot flashes in 72 women (age range: 43-57 years) who had (38 women), compared to those who had not (34 women), developed clinical insomnia in association with the menopausal transition. Sleep quality was assessed with two weeks of sleep diaries and one laboratory polysomnographic (PSG) recording. In multiple regression models controlling for menopausal transition stage, menstrual cycle phase, depression symptoms, and presence of objective hot flashes, a diagnosis of insomnia predicted PSG-measured total sleep time (p < 0.01), sleep efficiency (p = 0.01) and wakefulness after sleep onset (WASO) (p = 0.01). Women with insomnia had, on average, 43.5 min less PSG-measured sleep time (p < 0.001). There was little evidence of cortical EEG hyperarousal in insomniacs apart from elevated beta EEG power during REM sleep. Estradiol and follicle stimulating hormone levels were unrelated to beta EEG power but were associated with the frequency of hot flashes. Insomniacs were more likely to have physiological hot flashes, and the presence of hot flashes predicted the number of PSG-awakenings per hour of sleep (p = 0.03). From diaries, women with insomnia reported more WASO (p = 0.002), more night-to-night variability in WASO (p < 0.002) and more hot flashes (p = 0.012) compared with controls. Women who develop insomnia in the approach to menopause have a measurable sleep deficit, with almost 50% of the sample having less than 6h of sleep. Compromised sleep that develops in the context of the menopausal transition should be addressed, taking into account unique aspects of menopause like hot flashes, to avoid the known negative health consequences associated with insufficient sleep and insomnia in midlife women.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Estradiol; Health; Hot flashes; Insomnia; Menopause; Midlife women; Sleep

Mesh:

Substances:

Year:  2015        PMID: 26142241      PMCID: PMC4542146          DOI: 10.1016/j.psyneuen.2015.06.005

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  47 in total

Review 1.  Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones.

Authors:  Jessica A Mong; Fiona C Baker; Megan M Mahoney; Ketema N Paul; Michael D Schwartz; Kazue Semba; Rae Silver
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  The menopausal transition.

Authors:  Nanette Santoro
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

3.  Magnitude of the impact of hot flashes on sleep in perimenopausal women.

Authors:  Massimiliano de Zambotti; Ian M Colrain; Harold S Javitz; Fiona C Baker
Journal:  Fertil Steril       Date:  2014-09-23       Impact factor: 7.329

4.  The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.

Authors:  John F Randolph; MaryFran Sowers; Irina Bondarenko; Ellen B Gold; Gail A Greendale; Joyce T Bromberger; Sarah E Brockwell; Karen A Matthews
Journal:  J Clin Endocrinol Metab       Date:  2005-09-06       Impact factor: 5.958

5.  Evaluation of the association of menopausal status with delta and beta EEG activity during sleep.

Authors:  Ian G Campbell; Joyce T Bromberger; Daniel J Buysse; Martica H Hall; Kimberly A Hardin; Howard M Kravitz; Karen A Matthews; Marianne O'Neill Rasor; Jessica Utts; Ellen Gold
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

6.  Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort.

Authors:  Julio Fernandez-Mendoza; Alexandros N Vgontzas; Duanping Liao; Michele L Shaffer; Antonio Vela-Bueno; Maria Basta; Edward O Bixler
Journal:  Hypertension       Date:  2012-08-14       Impact factor: 10.190

Review 7.  Evaluation and management of sleep disturbance during the menopause transition.

Authors:  Hadine Joffe; Anda Massler; Katherine M Sharkey
Journal:  Semin Reprod Med       Date:  2010-09-15       Impact factor: 1.303

8.  Sleep duration and risk of ischemic stroke in postmenopausal women.

Authors:  Jiu-Chiuan Chen; Robert L Brunner; Hong Ren; Sylvia Wassertheil-Smoller; Joseph C Larson; Douglas W Levine; Matthew Allison; Michelle J Naughton; Marcia L Stefanick
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

9.  Insomnia with objective short sleep duration is associated with a high risk for hypertension.

Authors:  Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

10.  Short sleep duration is associated with risk of future diabetes but not cardiovascular disease: a prospective study and meta-analysis.

Authors:  Elizabeth G Holliday; Christopher A Magee; Leonard Kritharides; Emily Banks; John Attia
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more
  25 in total

1.  Sex differences in the association between social relationships and insomnia symptoms.

Authors:  Kyungmee Park; Daol Cho; Eun Lee; Junsol Kim; Jee-Seon Shim; Yoosik Youm; Suk Kyoon An; Kee Namkoong; Hyeon Chang Kim
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 2.  Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention.

Authors:  Sooyeon Suh; Nayoung Cho; Jihui Zhang
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

Review 3.  Sleep and Sleep Disorders in the Menopausal Transition.

Authors:  Fiona C Baker; Laura Lampio; Tarja Saaresranta; Päivi Polo-Kantola
Journal:  Sleep Med Clin       Date:  2018-09

4.  Altered nocturnal blood pressure profiles in women with insomnia disorder in the menopausal transition.

Authors:  Massimiliano de Zambotti; John Trinder; Harold Javitz; Ian M Colrain; Fiona C Baker
Journal:  Menopause       Date:  2017-03       Impact factor: 2.953

5.  Adverse Effects of Aromatase Inhibition on the Brain and Behavior in a Nonhuman Primate.

Authors:  Nicole J Gervais; Luke Remage-Healey; Joseph R Starrett; Daniel J Pollak; Jessica A Mong; Agnès Lacreuse
Journal:  J Neurosci       Date:  2018-12-26       Impact factor: 6.167

Review 6.  Symptoms of menopause - global prevalence, physiology and implications.

Authors:  Patrizia Monteleone; Giulia Mascagni; Andrea Giannini; Andrea R Genazzani; Tommaso Simoncini
Journal:  Nat Rev Endocrinol       Date:  2018-02-02       Impact factor: 43.330

Review 7.  Impact of sex steroids and reproductive stage on sleep-dependent memory consolidation in women.

Authors:  Fiona C Baker; Negin Sattari; Massimiliano de Zambotti; Aimee Goldstone; William A Alaynick; Sara C Mednick
Journal:  Neurobiol Learn Mem       Date:  2018-03-21       Impact factor: 2.877

8.  Menstrual cycle-related variation in autonomic nervous system functioning in women in the early menopausal transition with and without insomnia disorder.

Authors:  Massimiliano de Zambotti; John Trinder; Ian M Colrain; Fiona C Baker
Journal:  Psychoneuroendocrinology       Date:  2016-10-14       Impact factor: 4.905

9.  Sleep changes without medial temporal lobe or brain cortical changes in community-dwelling individuals with subjective cognitive decline.

Authors:  Mariella Lauriola; Roberto Esposito; Stefano Delli Pizzi; Massimiliano de Zambotti; Francesco Londrillo; Joel H Kramer; Gil D Rabinovici; Armando Tartaro
Journal:  Alzheimers Dement       Date:  2016-12-27       Impact factor: 21.566

10.  Acute stress alters autonomic modulation during sleep in women approaching menopause.

Authors:  Massimiliano de Zambotti; David Sugarbaker; John Trinder; Ian M Colrain; Fiona C Baker
Journal:  Psychoneuroendocrinology       Date:  2015-12-21       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.